Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Clinical trial NCT00034580 · COMPLETED

Trial details

NCT number: NCT00034580
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2001-08-01
Enrollment: 326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.